To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Coronavirus: Vaccination
Monday 16th October 2023

Asked by: Liz Saville Roberts (Plaid Cymru - Dwyfor Meirionnydd)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether laundry workers are eligible for the autumn Covid booster programme.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The primary aim of the COVID-19 vaccination programme continues to be the prevention of severe disease (hospitalisation and death) arising from COVID-19. The Joint Committee on Vaccination and Immunisation (JCVI) has recommended a targeted approach focussed on those most vulnerable to serious outcomes from COVID-19 including older individuals and individuals with specified existing clinical conditions.

On 8 August 2023, the Government accepted advice from the JCVI on who should be offered a COVID-19 vaccine in the autumn 2023 booster programme. This includes residents and staff in a care home for older adults, all adults aged 65 years old and over, persons aged six months to 64 years old in a clinical risk group, frontline health and social care workers, persons aged 12 to 64 years old who are household contacts and persons aged 16 to 64 years old who are carers.

Laundry workers are not, as a group, eligible for COVID-19 vaccination in autumn. However, if an individual is a laundry worker in a care home for older adults, a frontline health and social care worker or meets any of the other criteria for eligibility set out above, they are eligible for a COVID-19 vaccination. The objective of immunisation of frontline health and social care workers and staff working in care homes for older adults is to protect those workers at high risk of exposure who may also expose vulnerable individuals whilst providing care.


Written Question
Cancer: Research
Thursday 25th November 2021

Asked by: Liz Saville Roberts (Plaid Cymru - Dwyfor Meirionnydd)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of levels of funding available for research into (a) cures, (b) treatments and (c) diagnostic equipment for cancer; and what steps he is taking to increase research funding for those purposes.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

No such assessment has been made. The Department funds research through the National Institute for Health Research (NIHR). However, the NIHR does not categorise research in the format requested. Additionally, not all studies focus on a specific condition and aim to prevent or improve outcomes for multiple conditions.

The NIHR’s expenditure on cancer research has increased from £101 million in 2010/11 to £138 million in 2019/20 and the NIHR welcomes funding applications for research into any aspect of human health, including cancer.


Written Question
Global Health Insurance Card: Welsh Language
Tuesday 16th November 2021

Asked by: Liz Saville Roberts (Plaid Cymru - Dwyfor Meirionnydd)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether people applying for the UK's Global Health Insurance Card are able to complete the application form in Welsh.

Answered by Edward Argar - Minister of State (Ministry of Justice)

An applicant cannot apply for the UK Global Health Insurance Card (GHIC) in Welsh. The NHS Business Services Authority (NHSBSA), who are responsible for issuing the cards, are only able to accept applications in English. If a Welsh speaking customer wishes to contact the NHSBSA in relation to an EHIC or GHIC application a translation service is available.


Written Question
Global Health Insurance Card: Welsh Language
Thursday 4th November 2021

Asked by: Liz Saville Roberts (Plaid Cymru - Dwyfor Meirionnydd)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether the Global Health Insurance Card is available in English and Welsh.

Answered by Edward Argar - Minister of State (Ministry of Justice)

The Global Health Insurance Card (GHIC) is available in English and Welsh. Cardholders applying in Wales automatically receive the Welsh version of the GHIC card and accompanying letter which has a separate English translation.


Written Question
Mental Health Services: Veterans
Wednesday 3rd November 2021

Asked by: Liz Saville Roberts (Plaid Cymru - Dwyfor Meirionnydd)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of veterans that have received mental health support in each of the last five years.

Answered by Gillian Keegan - Secretary of State for Education

Veterans in England can access mental health support through Operation Courage Transition, Intervention and Liaison Service (TILS), the veteran’s specialist mental health service and the NHS Improving Access to Psychological Therapies (IAPT) service. The data for veterans accessing TILS and IAPT in each of the last five years is shown in the following table.

Financial year

Number of TILS assessments

Total number in receipt of TILS/ IAPT treatment

2017/2018

1,649

17,271

2018/2019

2,120

18,033

2019/2020

2,569

18,375

2020/2021

2,391

10,793

April to August 2021

1,052

4,294

It should be noted that IAPT data reports veterans who received treatment and declared their veteran status.


Written Question
Overseas Students: Coronavirus
Tuesday 8th June 2021

Asked by: Liz Saville Roberts (Plaid Cymru - Dwyfor Meirionnydd)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with (a) the Welsh Government and (b) Cabinet colleagues on developing alternatives to the hotel quarantine system for international students travelling to Wales from red list countries during the covid-19 outbreak, including controlled isolation conditions in university-managed accommodation.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

The Department has had regular engagement with the Developed Administrations, including the Welsh Government, throughout our shared response to the global pandemic. This has included policy development with my officials and Ministers also meet regularly with Welsh Government Ministers at the United Kingdom Health Ministers’ Forum. This forum discusses a range of topics, including managed quarantine.

We are currently exploring the policy options for international students travelling to the UK for Red-List countries. These discussions have included ensuring the system has the necessary capacity to respond to the potential increased demand from arrivals to the UK, including international students arriving from red-list countries. As we have done throughout this global health emergency, we will continue to take all steps necessary to protect the public and help prevent the spread of the virus.


Written Question
Travel: Quarantine
Tuesday 8th June 2021

Asked by: Liz Saville Roberts (Plaid Cymru - Dwyfor Meirionnydd)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the Welsh Government on the expected capacity constraints of the hotel quarantine system and international students from red-list countries who will be required to quarantine.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

The Department has had regular engagement with the Developed Administrations, including the Welsh Government, throughout our shared response to the global pandemic. This has included policy development with my officials and Ministers also meet regularly with Welsh Government Ministers at the United Kingdom Health Ministers’ Forum. This forum discusses a range of topics, including managed quarantine.

We are currently exploring the policy options for international students travelling to the UK for Red-List countries. These discussions have included ensuring the system has the necessary capacity to respond to the potential increased demand from arrivals to the UK, including international students arriving from red-list countries. As we have done throughout this global health emergency, we will continue to take all steps necessary to protect the public and help prevent the spread of the virus.


Written Question
Vitamin B12
Wednesday 27th January 2021

Asked by: Liz Saville Roberts (Plaid Cymru - Dwyfor Meirionnydd)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent discussions he has had with (a) the Welsh Government, (b) NHS England and (c) people with B12 deficiency on removing the classification of Prescription Only Medicine from injectable vitamin B12 and making B12 injectables available over the counter at pharmacies.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

Vitamin B12 is only available as an injection and therefore must be classified as prescription only under the regulations as suitable training needs to be given for its administration. The condition for which it is prescribed also means the product must be classified as a prescription only medicine and therefore no further assessment has been made of the potential merits of making these products available over the counter. Patients are prescribed vitamin B12 for pernicious anaemia and need medical input to diagnose, monitor their condition and treat it appropriately.

Formal discussions have therefore not been held with the Welsh Government or NHS England on the reclassification of vitamin B12. Officials have responded to patient enquiries to explain the rationale for the classification of this medicine as they have arisen.


Written Question
Vitamin B12
Wednesday 27th January 2021

Asked by: Liz Saville Roberts (Plaid Cymru - Dwyfor Meirionnydd)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits for those with B12 deficiency of removing the classification of Prescription Only Medicine from injectable vitamin B12 and making B12 injectables available over the counter at pharmacies.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

Vitamin B12 is only available as an injection and therefore must be classified as prescription only under the regulations as suitable training needs to be given for its administration. The condition for which it is prescribed also means the product must be classified as a prescription only medicine and therefore no further assessment has been made of the potential merits of making these products available over the counter. Patients are prescribed vitamin B12 for pernicious anaemia and need medical input to diagnose, monitor their condition and treat it appropriately.

Formal discussions have therefore not been held with the Welsh Government or NHS England on the reclassification of vitamin B12. Officials have responded to patient enquiries to explain the rationale for the classification of this medicine as they have arisen.


Written Question
Drugs: Imports
Monday 23rd November 2020

Asked by: Liz Saville Roberts (Plaid Cymru - Dwyfor Meirionnydd)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to help enable the unhindered movement of medicinal drugs from EU countries into the UK after the end of the transition period.

Answered by Jo Churchill - Minister of State (Department for Work and Pensions)

Our priority is to ensure that patients continue to have access to the medicines they need. We continue to work closely with industry, the National Health Service and others in the supply chain to deliver the shared goal of continuity of safe patient care by mitigating any potential disruption to supply into the United Kingdom of medicines at the end of the transition period.

As set out in a letter from the Department to industry of 3 August, we are implementing a multi-layered approach, that involves asking suppliers of medicines and medical products to the UK from or via the European Union to get trader ready, reroute their supply chains away from any potential disruption and stockpile to a target level of six weeks on UK soil where this is possible. The letter is available at the following link:

https://www.gov.uk/government/publications/letter-to-medicines-and-medical-products-suppliers-3-august-2020/letter-to-medicine-suppliers-3-august-2020